Zimmer Biomet Announces First Quarter 2019 Financial Results

Go back to Zimmer Biomet Announces First Quarter 2019 Financial Results

Zimmer Biomet (ZBH) PT Raised to $127 at Canaccord Genuity

April 26, 2019 1:27 PM EDT

Canaccord Genuity analyst Kyle Rose raised the price target on Zimmer Biomet (NYSE: ZBH) to $127.00 (from $125.00) while maintaining a Hold rating.

executing to plan but still early in the process... More

Zimmer Biomet (ZBH) PT Raised to $134 at RBC Capital

April 26, 2019 11:45 AM EDT

RBC Capital analyst Brandon Henry raised the price target on Zimmer Biomet (NYSE: ZBH) to $134.00 (from $128.00) while maintaining a Outperform rating following results.

Long-Term Turnaround Story Unchanged;... More

Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 1c, Revenues Beat

April 26, 2019 6:04 AM EDT

Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.87, $0.01 better than the analyst estimate of $1.86. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $1.96 billion.

"We delivered another solid quarter, driven by overall strong performance in the Asia... More